Lonza bone marrow and cord blood mononuclear cells

Monday, 18 April, 2011 | Supplied by: Capsugel Australia Pty Ltd


Lonza’s bone marrow and cord blood mononuclear cells are prepared by centrifugation in a density cell separation medium (Ficoll-Paque, Amersham Pharmacia).

Isolating the mononuclear cells eliminates erythrocytes and granulocytes, producing a more stable cell product.

Mononuclear cells can be used directly in hematopoietic assays or as the starting material for isolating CD34+ progenitor cells.

Cells are available cryopreserved with varying numbers or cells per ampule, starting from >25 million cells.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

EpigenTek EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) Kit

The kit is a complete set of optimised buffers and reagents designed to enrich an RNA fragment...

Cayman Chemical Off-Patent Drug Screening Library (96-Well)

Featuring a curated collection of FDA-approved compounds that are no longer covered under...

Norgen Biotek Bacterial EV Isolation Kit

The Bacterial EV Isolation Kit enables researchers to isolate extracellular vesicles directly...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd